Daniel Reuben to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications Daniel Reuben has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.048
-
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma. J Immunother Cancer. 2022 05; 10(5).
Score: 0.048
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.